Management of Failures in Medically Complex Cases and Failures of Periimplantitis - Part 3
with Dr. Shankar Iyer
Panelists
1 expert lined up.
About this webinar
The management of peri-implantitis in patients with breast cancer represents a clinically demanding intersection of implant dentistry, oncological therapeutics, bone metabolism, and host-mediated inflammatory responses. The increasing complexity of cancer treatment and survivorship care necessitates a refined understanding of how the systemic disease and pharmacological interventions influence the peri-implant tissue integrity, osseointegration, wound healing and the prognosis of the implant-supported rehabilitation. The management of peri-implant disease extends beyond conventional biofilm control and requires a comprehensive assessment of the cumulative biological consequences of therapeutic intervention. In this advanced webinar, Dr Shankar Iyer will critically examine the pathobiological mechanisms underlying implant complications in breast cancer patients, with emphasis on the interplay between chemotherapyinduced immunological and haematological alterations, endocrine therapyassociated changes in bone metabolism, and the exposure to antiresorptive or antiangiogenic agents. The clinical implications of bisphosphonates and denosumab are explored in relation to medication-related osteonecrosis of the jaw (MRONJ), while distinguishing medication-associated complications from plaque-induced peri-implantitis, impaired osseointegration, and other causes of progressive peri-implant bone loss. The therapeutic management of established peri-implantitis has been discussed through a risk-adapted framework incorporating disease severity, implant surface characteristics and medication-associated complications. The management of peri-implantitis in breast cancer patients demands a paradigm shift from conventional complication-oriented treatment towards a biologically informed and multidisciplinary model of care. The overarching clinical insight for the attendees is to move beyond the isolated management of peri-implant disease towards the precision-based management of the oncologically complex patient.
-
Date
Sun, 11 Oct 2026
-
Time
8:30 PM IST
-
CE credits
1 hours
-
Content Format
Live webinar
-
Access
Live + Recorded · Recording available afterwards
-
Certificate
Issued after attendance
-
Platform
Zoom Premium Webinar
-
Hosted by
Smile USA & Dentist Channel